AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • April 27th, 2005 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 27th, 2005 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of April 21, 2005, among Transkaryotic Therapies, Inc., a Delaware corporation (the “Company”), Shire Pharmaceuticals Group plc, a public limited company incorporated under the laws of England and Wales (“Parent”), and Sparta Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Subsidiary”).
AGREEMENT AND PLAN OF MERGER dated as of April 21, 2005 among TRANSKARYOTIC THERAPIES, INC., SHIRE PHARMACEUTICALS GROUP PLC and SPARTA ACQUISITION CORPORATIONAgreement and Plan of Merger • April 25th, 2005 • Shire Pharmaceuticals Group PLC • Pharmaceutical preparations • Delaware
Contract Type FiledApril 25th, 2005 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of April 21, 2005, among Transkaryotic Therapies, Inc., a Delaware corporation (the “Company”), Shire Pharmaceuticals Group plc, a public limited company incorporated under the laws of England and Wales (“Parent”), and Sparta Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Subsidiary”).